123 related articles for article (PubMed ID: 15834057)
1. Autoantibodies in biological agent naive patients with psoriatic arthritis.
Johnson SR; Schentag CT; Gladman DD
Ann Rheum Dis; 2005 May; 64(5):770-2. PubMed ID: 15834057
[TBL] [Abstract][Full Text] [Related]
2. Autoantibodies in patients with psoriatic arthritis on anti-TNFα therapy.
Viana VS; de Carvalho JF; de Moraes JC; Saad CG; Ribeiro AC; Gonçalves C; Bueno C; Vendramini MB; Bonfá E
Rev Bras Reumatol; 2010; 50(3):225-34. PubMed ID: 21125159
[TBL] [Abstract][Full Text] [Related]
3. The clinical and genetic associations of anti-cyclic citrullinated peptide antibodies in psoriatic arthritis.
Korendowych E; Owen P; Ravindran J; Carmichael C; McHugh N
Rheumatology (Oxford); 2005 Aug; 44(8):1056-60. PubMed ID: 15901902
[TBL] [Abstract][Full Text] [Related]
4. Early effects of tumour necrosis factor alpha blockade on skin and synovial tissue in patients with active psoriasis and psoriatic arthritis.
Goedkoop AY; Kraan MC; Teunissen MB; Picavet DI; de Rie MA; Bos JD; Tak PP
Ann Rheum Dis; 2004 Jul; 63(7):769-73. PubMed ID: 15194570
[TBL] [Abstract][Full Text] [Related]
5. A follow-up study in 28 patients treated with infliximab for severe recalcitrant psoriasis: evidence for efficacy and high incidence of biological autoimmunity.
Poulalhon N; Begon E; Lebbé C; Lioté F; Lahfa M; Bengoufa D; Morel P; Dubertret L; Bachelez H
Br J Dermatol; 2007 Feb; 156(2):329-36. PubMed ID: 17223874
[TBL] [Abstract][Full Text] [Related]
6. Infliximab, but not etanercept, induces IgM anti-double-stranded DNA autoantibodies as main antinuclear reactivity: biologic and clinical implications in autoimmune arthritis.
De Rycke L; Baeten D; Kruithof E; Van den Bosch F; Veys EM; De Keyser F
Arthritis Rheum; 2005 Jul; 52(7):2192-201. PubMed ID: 15986349
[TBL] [Abstract][Full Text] [Related]
7. Autoantibodies profile of rheumatoid arthritis patients during treatment with infliximab.
Elkayam O; Burke M; Vardinon N; Zakut V; Yitzhak RB; Paran D; Levartovsky D; Litinsky I; Caspi D
Autoimmunity; 2005 Mar; 38(2):155-60. PubMed ID: 16040336
[TBL] [Abstract][Full Text] [Related]
8. Autoantibody formation in patients with rheumatoid arthritis treated with anti-TNF alpha.
Eriksson C; Engstrand S; Sundqvist KG; Rantapää-Dahlqvist S
Ann Rheum Dis; 2005 Mar; 64(3):403-7. PubMed ID: 15297281
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and tolerability of anti-tumour necrosis factor therapy in psoriatic arthritis patients: results from the South Swedish Arthritis Treatment Group register.
Kristensen LE; Gülfe A; Saxne T; Geborek P
Ann Rheum Dis; 2008 Mar; 67(3):364-9. PubMed ID: 17644547
[TBL] [Abstract][Full Text] [Related]
10. Autoantibodies in systemic lupus erythematosus: comparison of historical and current assessment of seropositivity.
Ippolito A; Wallace DJ; Gladman D; Fortin PR; Urowitz M; Werth V; Costner M; Gordon C; Alarcón GS; Ramsey-Goldman R; Maddison P; Clarke A; Bernatsky S; Manzi S; Bae SC; Merrill JT; Ginzler E; Hanly JG; Nived O; Sturfelt G; Sanchez-Guerrero J; Bruce I; Aranow C; Isenberg D; Zoma A; Magder LS; Buyon J; Kalunian K; Dooley MA; Steinsson K; van Vollenhoven RF; Stoll T; Weisman M; Petri M
Lupus; 2011 Mar; 20(3):250-5. PubMed ID: 21362750
[TBL] [Abstract][Full Text] [Related]
11. Low frequency of anticyclic citrullinated peptide antibodies in psoriatic arthritis but not in cutaneous psoriasis.
Candia L; Marquez J; Gonzalez C; Santos AM; Londoño J; Valle R; Zabaleta J; Yaqub Z; Espinoza LR
J Clin Rheumatol; 2006 Oct; 12(5):226-9. PubMed ID: 17023808
[TBL] [Abstract][Full Text] [Related]
12. The significance of persistent newly developed autoantibodies in JIA patients under long-term anti-TNF treatment.
Kanakoudi-Tsakalidou F; Tzimouli V; Pratsidou-Gertsi P; Chronopoulou E; Trachana M
Cytokine; 2008 Jun; 42(3):293-7. PubMed ID: 18445529
[TBL] [Abstract][Full Text] [Related]
13. Effects of etanercept on C-reactive protein levels in psoriasis and psoriatic arthritis.
Strober B; Teller C; Yamauchi P; Miller JL; Hooper M; Yang YC; Dann F
Br J Dermatol; 2008 Aug; 159(2):322-30. PubMed ID: 18503600
[TBL] [Abstract][Full Text] [Related]
14. Blockade of tumour necrosis factor {alpha} significantly alters the serum level of IgG- and IgA-rheumatoid factor in patients with rheumatoid arthritis.
Yazdani-Biuki B; Stadlmaier E; Mulabecirovic A; Brezinschek R; Tilz G; Demel U; Mueller T; Brickmann K; Graninger WB; Brezinschek HP
Ann Rheum Dis; 2005 Aug; 64(8):1224-6. PubMed ID: 16014683
[TBL] [Abstract][Full Text] [Related]
15. Anti-RO anti-LA anti-RNP antibodies and eletrocardiogram's PR interval in adult patients with systemic lupus erythematosus.
Costa M; Gameiro Silva MB; Silva JA; Skare TL
Acta Reumatol Port; 2008; 33(2):173-6. PubMed ID: 18604183
[TBL] [Abstract][Full Text] [Related]
16. Concentration of antibodies to extractable nuclear antigens and disease activity in systemic lupus erythematosus.
Agarwal S; Harper J; Kiely PD
Lupus; 2009 Apr; 18(5):407-12. PubMed ID: 19318392
[TBL] [Abstract][Full Text] [Related]
17. Is antibody clustering predictive of clinical subsets and damage in systemic lupus erythematosus?
To CH; Petri M
Arthritis Rheum; 2005 Dec; 52(12):4003-10. PubMed ID: 16320348
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of autoantibodies in SAPHO syndrome: a single-center study of 90 patients.
Grosjean C; Hurtado-Nedelec M; Nicaise-Roland P; Ferreyra-Dillon R; Bollet C; Quintin E; Dieude P; Palazzo E; Wattiaux MJ; Kahn MF; Meyer O; Chollet-Martin S; Hayem G
J Rheumatol; 2010 Mar; 37(3):639-43. PubMed ID: 20110527
[TBL] [Abstract][Full Text] [Related]
19. Anti-20S proteasome antibodies in psoriatic arthritis.
Colmegna I; Sainz B; Citera G; Maldonado-Cocco JA; Garry RF; Espinoza LR
J Rheumatol; 2008 Apr; 35(4):674-6. PubMed ID: 18278835
[TBL] [Abstract][Full Text] [Related]
20. Follow-up of psoriatic arthritis mutilans patients treated with anti-TNF-alpha therapy.
Pomerantz RG; Mody E; Husni ME; Qureshi AA
J Drugs Dermatol; 2009 Apr; 8(4):406-12. PubMed ID: 19363860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
